The conference begins Oct. 13 in NYC. The post 5 Things To Not Miss At Horizons Psychedelics Conference appeared first on Green Market Report.
Psychedelic drug maker Reunion Neuroscience (Nasdaq: REUN), formerly known as Field Trip Health, announced that Ronan Levy has stepped down from the board...
A new generation of patients can be powerful motivators for a pharmaceutical industry historically resistant to change. And if they don’t respect or...
Source: Dr. Elemer Piros 10/06/2022 Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10...
The article atai Life Sciences Doses First Patient in New DMT Clinical Trial was originally published on Microdose. While atai Life Sciences (Nasdaq:...
The article Can Psychedelic Stocks Like MindMed and atai Ever Recover? was originally published on Microdose. Should investors begin ringing the funeral...
Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research,...
The article News You Might Have Missed: Oct 3rd, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
To broaden the appeal of therapist-assisted psychedelics, a number of companies are engineering out the hallucinogenic aspect. The post Researchers Seek...
The article MindMed in Trouble? Serious Problems or Retail Panic? was originally published on Microdose. MindMed in trouble? What a nice attention-grabbing...